Page 18 - World Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients with xanthelasma palpebrarum have a higher risk of progression to non-alcoholic fatty liver disease and developing more severe dyslipidemia. Learn more

Article In Brief In the wake of blood-clotting disorders in six young women who had been vaccinated with the single Johnson & Johnson COVID-19 vaccine, neurovascular neurologists and hematologists address questions about assessing risks and managing the side effects. Neurologists are getting queries from anxious patients in the aftermath of a nationwide “temporary” pause in administration of the single-shot Janssen/Johnson & Johnson COVID-19 vaccine. As of April 12, more than 6.8 million doses of the Janssen vaccine were administered around the country. Two days later, it climbed to 7.2 m...

Son helps dad after back surgery, then dad helps son after stroke Tate Gunnerson, American Heart Association News May 7, 2021 FacebookTwitterEmail When 81-year-old Dick Connery had back surgery in 2019, his son Tim Connery became his primary caregiver. Tim moved in temporarily, ran errands and kept his dad company. Then, Tim said, "in the blink of an eye, things changed." One morning, about three weeks after Dick's surgery, 57-year-old Tim woke up feeling confused and out of sorts. Nevertheless, he continued about his day, even hopping in the car to run errands. Increasingly dizzy, he passed ...

-The World Stroke Organization Advises Public to be Vigilant for Symptoms of Rare Stroke Linked to Johnson & Johnson and AstraZeneca COVID Vaccines. - The World Stroke Organization is calling for increased awareness of the symptoms of a rare type of stroke that has been linked to a Johnson & Johnson and AstraZeneca COVID-19 vaccines. The call follows the suspension of administration of the Johnson & Johnson vaccine in the US and recent changes to clinical guidance on the use of the AstraZeneca in Europe, due to the rare occurrence of cerebral venous sinus thrombosis (CVST) in patients who hav...

(2) Wearable cardiac monitoring solution enables early detection and treatment of arrhythmia based on risk factors, according to results of the SCREEN-AF study published in JAMA Cardiology iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the results of a brand new "SCREEN-AF" study, led by researchers at Sunnybrook Health Sciences Centre in Toronto, Canada and University Hospital in Leipzig, Germany, which was published in JAMA Cardiology The transatlantic clinical trial found that Zio by ...